{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:38:20Z","timestamp":1759178300152,"version":"3.38.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001786","name":"The University of Adelaide","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03045-5","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:01:55Z","timestamp":1714737715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sulfonamides in ophthalmology: adverse reactions"],"prefix":"10.1007","volume":"44","author":[{"given":"David","family":"Daniel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Casson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"issue":"1","key":"3045_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.18773\/austprescr.2008.006","volume":"31","author":"WB Smith","year":"2008","unstructured":"Smith WB, Katelaris CH (2008) \u2018Sulfur allergy\u2019 label is misleading. Aust Prescr 31(1):8\u201310","journal-title":"Aust Prescr"},{"key":"3045_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s12016-021-08872-3","volume":"62","author":"TG Chow","year":"2022","unstructured":"Chow TG, Khan DA (2022) Sulfonamide hypersensitivity. Clin Rev Allerg Immunol 62:400\u2013412. https:\/\/doi.org\/10.1007\/s12016-021-08872-3","journal-title":"Clin Rev Allerg Immunol"},{"key":"3045_CR3","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/B978-1-4557-0737-9.00089-8","volume-title":"Retina","author":"RA Mittra","year":"2013","unstructured":"Mittra RA, Mieler WF (2013) Drug toxicity of the posterior segment. In: Ryan SJ, Sadda SR, Hinton DR, Schachat AP, Sadda SR, Wilkinson CP, Wiedemann P, Schachat AP (eds) Retina, 5th edn. W.B. Saunders, Philadelphia, pp 1532\u20131554. https:\/\/doi.org\/10.1016\/B978-1-4557-0737-9.00089-8","edition":"5"},{"key":"3045_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/DDDT.S38324","volume":"7","author":"R Malagola","year":"2013","unstructured":"Malagola R, Arrico L, Giannotti R, Pattavina L (2013) Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement. Drug Des Dev Ther 7:33\u201336. https:\/\/doi.org\/10.2147\/DDDT.S38324","journal-title":"Drug Des Dev Ther"},{"issue":"2","key":"3045_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40123-018-0136-8","volume":"7","author":"TJ Shah","year":"2018","unstructured":"Shah TJ, Moshirfar M, Hoopes PC (2018) \u2018Doctor, i have a sulfa allergy\u2019: clarifying the myths of cross-reactivity. Ophthalmol Therapy 7(2):211\u2013215. https:\/\/doi.org\/10.1007\/s40123-018-0136-8","journal-title":"Ophthalmol Therapy"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03045-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03045-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03045-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:21:29Z","timestamp":1741879289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03045-5"}},"subtitle":["Evidence-based use of sulfa drugs in ophthalmology"],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3045"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03045-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"14 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"214"}}